The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Weill Cornell Medical College - $91,740

Amount
$91,740.00
Date
March 2010

Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.

St. Jude's Children's Research Hospital - $10,000

Amount
$10,000.00
Date
July 2009

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
July 2009

National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $50,000

Amount
$50,000.00
Date
July 2009

Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
September 2008

Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $25,000

Amount
$25,000.00
Date
September 2008

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.